3QBK
Bromide-bound form of pharaonis halorhodopsin
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SPRING-8 BEAMLINE BL26B2 |
Synchrotron site | SPring-8 |
Beamline | BL26B2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2010-04-07 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 0.912 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 152.150, 99.720, 99.970 |
Unit cell angles | 90.00, 127.80, 90.00 |
Refinement procedure
Resolution | 15.000 - 2.200 |
R-factor | 0.2482 |
Rwork | 0.248 |
R-free | 0.26690 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3a7k |
RMSD bond length | 0.006 |
RMSD bond angle | 1.135 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | CNS |
Refinement software | CNS |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 49.900 | 2.320 |
High resolution limit [Å] | 2.200 | 2.200 |
Rmerge | 0.095 | 0.501 |
Number of reflections | 58115 | |
<I/σ(I)> | 5.2 | 2.5 |
Completeness [%] | 97.2 | 82.9 |
Redundancy | 3.8 | 3.8 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 9 | 288 | Crystallization: 3.5 mg/ml halorhodopsin, 5mg/ml nonylglucoside, 2.8M ammonium sulfate, 0.1 M glycine, 0.1M NaCl Post-crystallization soaking: 0.1 M Sodium Bromide, 3 M ammonium sulfate, 0.1 M Hepes (pH7), 30% trehalose , pH 9.0, VAPOR DIFFUSION, SITTING DROP, temperature 288K |